Cargando…

Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies

Bone fragility is recognized as one of the major comorbidities in Turner syndrome (TS). The mechanisms underlying bone impairment in affected patients are not clearly elucidated, but estrogen deficiency and X-chromosomal abnormalities represent important factors. Moreover, although many girls with T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faienza, Maria Felicia, Ventura, Annamaria, Colucci, Silvia, Cavallo, Luciano, Grano, Maria, Brunetti, Giacomina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844601/ https://www.ncbi.nlm.nih.gov/pubmed/27199891 http://dx.doi.org/10.3389/fendo.2016.00034

Ejemplares similares

Mechanisms Involved in Childhood Obesity-Related Bone Fragility
por: Faienza, Maria Felicia, et al.
Publicado: (2019)

Skeleton and Glucose Metabolism: A Bone-Pancreas Loop
por: Faienza, Maria Felicia, et al.
Publicado: (2015)

Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
por: Ventura, Annamaria, et al.
Publicado: (2013)

Osteoclastogenic Potential of Peripheral Blood Mononuclear Cells in Cleidocranial Dysplasia
por: Faienza, Maria Felicia, et al.
Publicado: (2014)

Type 2 diabetes and bone fragility in children and adults
por: Faienza, Maria Felicia, et al.
Publicado: (2022)

Editorial: Updates on Osteoimmunology: What's New on the Crosstalk Between Bone and Immune Cells
por: Brunetti, Giacomina, et al.
Publicado: (2020)

Editorial: Bone: Endocrine Target and Organ
por: Brunetti, Giacomina, et al.
Publicado: (2017)

Mechanisms of altered bone remodeling in children with type 1 diabetes
por: Brunetti, Giacomina, et al.
Publicado: (2021)

Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents
por: Brunetti, Giacomina, et al.
Publicado: (2020)

Metabolic Bone Disease of Prematurity: Diagnosis and Management
por: Faienza, Maria Felicia, et al.
Publicado: (2019)

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens
por: Brunetti, Giacomina, et al.
Publicado: (2018)

Editorial: Special Issue on “Molecular Mechanisms Regulating Osteoclastogenesis”
por: Brunetti, Giacomina, et al.
Publicado: (2020)

Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects
por: Colaianni, Graziana, et al.
Publicado: (2019)

Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
por: Chiarito, M., et al.
Publicado: (2022)

The p53 family member p73 modulates the proproliferative role of IGFBP3 in short children born small for gestational age
por: Marzano, Flaviana, et al.
Publicado: (2015)

Pediatric Type 1 Diabetes: Mechanisms and Impact of Technologies on Comorbidities and Life Expectancy
por: Urbano, Flavia, et al.
Publicado: (2023)

The Role of TNF-α and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease
por: Galeone, Antonella, et al.
Publicado: (2013)

Postmenopausal Osteoporosis: The Role of Immune System Cells
por: Faienza, Maria Felicia, et al.
Publicado: (2013)

Editorial: Insights in bone research 2021
por: Tobias, Jonathan H., et al.
Publicado: (2022)

Editorial: Insights in bone research: 2022
por: Brunetti, Giacomina, et al.
Publicado: (2023)

LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease
por: Brunetti, Giacomina, et al.
Publicado: (2014)

Effects of Sweet Cherry Polyphenols on Enhanced Osteoclastogenesis Associated With Childhood Obesity
por: Corbo, Filomena, et al.
Publicado: (2019)

Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications
por: Galeone, Antonella, et al.
Publicado: (2023)

Irisin Enhances Osteoblast Differentiation In Vitro
por: Colaianni, Graziana, et al.
Publicado: (2014)

Hyperglycemia in Turner syndrome: Impact, mechanisms, and areas for future research
por: Mitsch, Cameron, et al.
Publicado: (2023)

Fracture risk, underlying pathophysiology, and bone quality assessment in patients with Turner syndrome
por: Ikegawa, Kento, et al.
Publicado: (2022)

Glucose Metabolism in Turner Syndrome
por: Sun, Lin, et al.
Publicado: (2019)

Growth in girls with Turner syndrome
por: Isojima, Tsuyoshi, et al.
Publicado: (2023)

Advances and Unmet Needs in the Therapeutics of Bone Fragility
por: Ramchand, Sabashini K., et al.
Publicado: (2018)

Novel insights in health-promoting properties of sweet cherries
por: Faienza, Maria Felicia, et al.
Publicado: (2020)

Autoimmunity Predisposition in Girls With Turner Syndrome
por: Wegiel, Malgorzata, et al.
Publicado: (2019)

Ovarian dysfunction in women with Turner syndrome
por: Fukami, Maki
Publicado: (2023)

Investigating the role of ASCC1 in the causation of bone fragility
por: Voraberger, Barbara, et al.
Publicado: (2023)

Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice
por: Colaianni, Graziana, et al.
Publicado: (2017)

Mechanisms of Bone Impairment in Sickle Bone Disease
por: Giordano, Paola, et al.
Publicado: (2021)

Risk Factors for Subclinical Atherosclerosis in Diabetic and Obese Children
por: Faienza, Maria Felicia, et al.
Publicado: (2013)

Immunological Profile and Predisposition to Autoimmunity in Girls With Turner Syndrome
por: Gawlik, Aneta Monika, et al.
Publicado: (2018)

Genetic, epigenetic and enviromental influencing factors on the regulation of precocious and delayed puberty
por: Faienza, Maria Felicia, et al.
Publicado: (2022)

Periodontal Disease: Linking the Primary Inflammation to Bone Loss
por: Di Benedetto, Adriana, et al.
Publicado: (2013)

The genetic background and vitamin D supplementation can affect irisin levels in Prader–Willi syndrome
por: Faienza, M. F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p699hqob5fvt4ts2cpon544qku